Massive disruptions at the National Institutes of Health, job cuts, and choked off funding inflict pain far and wide
Many are filling vacancies created by the ouster of predecessors as part of Trump administration’s reshaping of science and health agencies
Trump's second term is playing out a lot differently than health care companies and their lobbyists hoped for.
The departures appear to run counter to health secretary Robert F. Kennedy Jr.'s goal of eliminating conflicts of interest.
New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study
Hospitals and health plans are concerned about price hikes, although VUMC is taking a particularly aggressive stance.
Work on Li-Fraumeni syndrome, which makes people susceptible to a host of cancers, could be set back years or even decades because of NIH cuts.
The ruling is the latest development in the fight between compounding pharmacies and pharma companies over who can make GLP-1 drugs and when.
